PRICE T ROWE ASSOCIATES INC /MD/
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,247,525
+$309,908 QoQ
Shares Held
103,287
+14.7% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. SRPT ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,247,525 | 103,287 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,937,617 | 90,038 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,734,819 | 90,027 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,313,005 | 76,784 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,204,986 | 238,248 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $29,383,803 | 241,663 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,540,606 | 236,533 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,724,740 | 340,030 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $65,373,157 | 504,968 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $71,332,741 | 739,736 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $95,516,025 | 787,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $89,431,072 | 780,921 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $161,459,850 | 1,171,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $108,418,678 | 836,693 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $134,733,999 | 1,218,871 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $87,241,971 | 1,163,847 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $88,807,206 | 1,136,805 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,236,997 | 735,558 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $65,609,381 | 709,444 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $56,065,466 | 721,192 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $52,480,523 | 704,153 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,088,968 | 1,302,651 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $188,324,072 | 1,341,053 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $251,152,246 | 1,566,373 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $165,002,678 | 1,686,799 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||